Drug Type Therapeutic vaccine |
Synonyms- |
Target |
Action agonists |
Mechanism FSHR agonists(Follicle-stimulating hormone receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Ovarian Cancer | Preclinical | United States | 09 Jan 2024 | |
| Ovarian Cancer | Preclinical | United States | 09 Jan 2024 | |
| Ovarian Cancer | Preclinical | United States | 09 Jan 2024 |





